Showing results (1-10 of 13) with videos related to
Sort By:
Pageof 2
Exploration of Targeted Anti-Tumor Therapy|September 1, 2022
Aptamers and antibodies: rivals or allies in cancer targeted therapy?Lisa Agnello, Simona Camorani, Monica Fedele, et al.Pharmaceutics|January 21, 2022
Profiling Cancer Cells by Cell-SELEX: Use of Aptamers for Discovery of Actionable Biomarkers and Therapeutic Applications ThereofSarah Shigdar, Lisa Agnello, Monica Fedele, et al.Cancers|April 13, 2023
Aptamer-Based Strategies to Boost Immunotherapy in TNBCLisa Agnello, Annachiara d'Argenio, Roberto Nilo, et al.Cells|July 14, 2023
Tissue Inhibitor of Metalloproteinases-1 Overexpression Mediates Chemoresistance in Triple-Negative Breast Cancer CellsLisa Agnello, Annachiara d'Argenio, Alessandra Caliendo, et al.International Journal of Molecular Sciences|April 12, 2022
Optimization of Short RNA Aptamers for TNBC Cell TargetingSimona Camorani, Annachiara d'Argenio, Lisa Agnello, et al.Pharmaceutics|October 26, 2024
Correction: Ibarra et al. Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer Nanoparticles. Pharmaceutics 2022, 14, 626Luis Exequiel Ibarra, Simona Camorani, Lisa Agnello, et al.Pharmaceutics|March 26, 2022
Selective Photo-Assisted Eradication of Triple-Negative Breast Cancer Cells through Aptamer Decoration of Doped Conjugated Polymer NanoparticlesLuis Exequiel Ibarra, Simona Camorani, Lisa Agnello, et al.Biomaterials Science|October 27, 2025
A red emitting carbon dot and aptamer-functionalized alginate system for targeted triple-negative breast cancer imagingSimone Maturi, Alessandra Caliendo, Silvia Tortorella, et al.Pharmaceutics|October 27, 2022
Aptamer-Functionalized Nanoparticles Mediate PD-L1 siRNA Delivery for Effective Gene Silencing in Triple-Negative Breast Cancer CellsSimona Camorani, Silvia Tortorella, Lisa Agnello, et al.Journal of Experimental & Clinical Cancer Research : CR|July 23, 2021
Optimizing cisplatin delivery to triple-negative breast cancer through novel EGFR aptamer-conjugated polymeric nanovectorsLisa Agnello, Silvia Tortorella, Annachiara d'Argenio, et al.Pageof 2